Industry

AI-powered supply chain orchestration and rare-disease innovation join forces for faster delivery of critical therapies to patients in need OTTAWA, Ontario–(BUSINESS WIRE)–Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration today announced that Swedish Orphan Biovitrum AB (Sobi), a leading international biopharmaceutical company, has elected to implement the Kinaxis Maestro® platform to facilitate end-to-end … [Read more…]

The program aims to deliver better guidance for physicians and ultimately improve outcomes for pancreatic cancer patients. BOSTON–(BUSINESS WIRE)–#NGS–Genialis, the RNA biomarker company, today announced a collaboration with Cleveland Clinic, one of the world’s leading academic medical centers, to develop AI-powered tools that help doctors identify the most effective treatment options for patients with pancreatic … [Read more…]

Dutch biotech Leyden Labs has raised a €30 million equity investment from the European Innovation Council (EIC) Fund and Invest-NL to accelerate the development of its PanFlu nasal spray, as well as the Company’s other mucosal pipeline and platform activities. The support from the EIC Fund and Invest-NL helps strengthen Europe’s preparedness against current and … [Read more…]

GARDENA, Calif.–(BUSINESS WIRE)–Boarding for Breast Cancer (B4BC) is thrilled to announce its Breast Cancer Awareness Month initiatives, with a wide range of opportunities for supporters to rally behind this important month. All October long, B4BC will be partnering with action sports brands and organizations that reinforce its mission of early detection + a healthy, active … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Doctible, a leader in patient engagement and practice growth solutions, today announced the launch of two powerful additions to its platform: Patient Link and Doctible Websites. Designed to stimulate growth, without adding additional work for practice owners or their teams, these new solutions simplify operations, strengthen patient connections, and promote profitability. Patient Link … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Adeno-Associated Viral (AAV) Vector Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapy, Therapeutic Area, Route of Administration, Scale of Operation and Geographical Regions” report has been added to ResearchAndMarkets.com’s offering. The global AAV vector market estimated to be 3.6 billion in the current year and USD 6.0 billion … [Read more…]

The panel, entitled “Mitigating Tissue Damage in Radiation Oncology and Inflammation in Pulmonary Disease: Targeting Pathways of Tissue Injury and Inflammatory Response,” will explore advances in unmet medical needs for oncology-related radiation exposure and pulmonary disease-related inflammation MINNEAPOLIS–(BUSINESS WIRE)–Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company pioneering novel approaches to tissue protection in oncology-related radiation … [Read more…]

Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease Fast Track Designation recognizes the potential of anti-MTBR tau to be an important treatment option for patients with Alzheimer’s disease PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #Alzheimers—Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration … [Read more…]

Adding Spevigo® is a significant step forward in LEO Pharma’s focused growth strategy, to accelerate and expand patients’ access to treatments for medical dermatological conditions, including generalized pustular psoriasis (GPP), a rare and severe skin condition Spevigo® (spesolimab) is a first-in-class IL-36R antagonist successfully developed and launched by Boehringer Ingelheim and approved globally for the … [Read more…]

Offering was led by an initial investment from a premier healthcare-dedicated investor alongside multiple large existing shareholders Company’s total cash position expected to be approximately $70 million following closing VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (the “Company”), a commercial-stage biopharmaceutical company dedicated to developing innovative treatments for neurodegenerative diseases, today announced … [Read more…]